The IVD Quantitative Tyrosine Kinase-1 Assay of the fms-like Form - Vietnam Registration 2403590ĐKLH/BYT-HTTB
Access comprehensive regulatory information for The IVD Quantitative Tyrosine Kinase-1 Assay of the fms-like Form in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loại C medical device is registered under number 2403590ĐKLH/BYT-HTTB and manufactured by Siemens Healthcare Diagnostics Products Ltd. The authorized representative in Vietnam is CÔNG TY TNHH SIEMENS HEALTHCARE.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2403590ĐKLH/BYT-HTTB
18007776/ĐKLH-BYT-TB-CT
Theo theo phụ lục
Theo phụ lục
Technical Details
- Atellica IM sFlt-1: The Atellica IM Soluble fms-like Tyrosine Kinase-1 (sFlt-1) test is used for in vitro diagnosis to quantify the concentration of the soluble form of fms-like tyrosine kinase-1 (sFlt-1) in human plasma and serum (K2 EDTA) using the Atellica IM Analyzer and Atellica CI Analyzer. The Atellica IM sFlt-1 test is used in combination with the Atellica IM PlGF test to determine the sFlt-1/PlGF ratio (PE ratio). The PE ratio is used as a predictive marker for preterm birth and adverse outcomes in women with signs and symptoms of preeclampsia. - Atellica IM sFlt-1 QC: The AtellicaIM sFlt-1 Quality Control (sFlt-1QC) test is used for in vitro diagnosis to monitor the accuracy and precision of the AtellicaIM sFlt-1 test.
Dates and Status
Nov 14, 2024